Dimopoulos M, Tedeschi A, Trotman J, et al. Multinational, randomized phase 3 trial of ibrutinib-rituximab vs placebo-rituximab with Waldenström’s macroglobulinemia. EHA 2018, abstract S852.
Impact van CAR T-celtherapie op effectiviteit mosunetuzumab bij R/R B-cellymfomen
mrt 2025 | Lymfoom